Box–Behnken Design Optimization of High-Pressure Processed Bitter Melon (Momordica charantia) Leaf Extract Enhancing Phytochemicals, Anticancer, and Anti-Inflammatory Activities
International Journal of Molecular Sciences · 29.05.2026 · 27 (11) · 4945
DOI: 10.3390/ijms27114945 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.05.2026. Verfasst von Kongsakon Kulchim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate/Ph.D. Program in Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Momordica charantia, Plant Extracts, Anti-Inflammatory Agents, Plant Leaves. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Faculty of Medicine Research Fund.
Abstract (Originalsprache)
Bitter Melon Leaf Extract (BMLE) possesses potential anticancer and anti-inflammatory properties; however, conventional extraction methods restrict phytochemical yield and bioactivity. Here, we optimized extraction using High-Pressure Processing (HPP) with Box–Behnken Design (BBD) and Response Surface Methodology (RSM). The optimized extract (O-BMLE) demonstrated significantly higher total flavonoid content (27.7 vs. 8.7 mg RE/g) and FRAP antioxidant capacity (96.5 vs. 71.2 μmol TE/g) compared to conventional BMLE. Additionally, O-BMLE exhibited enhanced cytotoxicity (A549 IC50: 58.7 vs. 147 μg/mL) and selectivity (SI: 5.03 vs. 2.60) against A549, HepG2, and SKOV3 cancer cells while showing minimal effects on 3T3-L1 fibroblasts. In LPS-stimulated RAW264.7 macrophages, O-BMLE selectively inhibited JNK phosphorylation without affecting NF-κB phosphorylation, resulting in suppression of iNOS, COX-2, IL-1β, IL-6, and TNF-α expression as well as nitric oxide production. HPLC analysis revealed equivalent momordicine-I levels (~28 mg/g) between extracts. In contrast, HPLC-qTOF-MS profiling revealed that O-BMLE was enriched in stearidonic acid (66% increase in relative abundance), 4-hydroxybenzoic acid (19.5%), monolinolenin, 6-gingerol, and pedunculoside, which are compounds linked to JNK inhibition, antioxidant activity, and cytokine suppression. These results indicate that HPP-BBD/RSM optimization selectively modifies the bitter melon leaf metabolome, thereby enhancing anticancer and anti-inflammatory activities independently of momordicine-I content alone. O-BMLE may therefore serve as a promising candidate for the development of functional foods and nutraceuticals targeting inflammation-associated cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate/Ph.D. Program in Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
- Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
- Faculty of Agro-Industry, Chiang Mai University, Chiang Mai 50100, Thailand.
- Institute of Nutrition, Mahidol University, Salaya, Nakhon Pathom 73170, Thailand.
- Department of Oral Biology, Faculty of Dentistry, Mahidol University, Bangkok 10400, Thailand.
ORCID-Profile: Kongsakon Kulchim, Sukan Braspaiboon, Pornsiri Pitchakarn, Arisa Imsumran, Pensiri Buacheen, Tanongsak Laowanitwattana, Piya Temviriyanukul, Ariyaphong Wongnoppavich
Förderung
- National Research Council of Thailand
- Faculty of Medicine Research Fund
Zitieren
APA
Kulchim, K., Braspaiboon, S., Pitchakarn, P., Imsumran, A., Buacheen, P., Laowanitwattana, T., Temviriyanukul, P., Chairatvit, K., & Wongnoppavich, A. (2026). Box–Behnken Design Optimization of High-Pressure Processed Bitter Melon (Momordica charantia) Leaf Extract Enhancing Phytochemicals, Anticancer, and Anti-Inflammatory Activities. International Journal of Molecular Sciences, 27(11), 4945. https://doi.org/10.3390/ijms27114945
Vancouver
Kulchim K, Braspaiboon S, Pitchakarn P, Imsumran A, Buacheen P, Laowanitwattana T, et al. Box–Behnken Design Optimization of High-Pressure Processed Bitter Melon (Momordica charantia) Leaf Extract Enhancing Phytochemicals, Anticancer, and Anti-Inflammatory Activities. International Journal of Molecular Sciences. 2026;27(11):4945. doi:10.3390/ijms27114945
BibTeX
@article{Kulchim2026,
author = {Kulchim, Kongsakon and Braspaiboon, Sukan and Pitchakarn, Pornsiri and Imsumran, Arisa and Buacheen, Pensiri and Laowanitwattana, Tanongsak and Temviriyanukul, Piya and Chairatvit, Kongthawat and Wongnoppavich, Ariyaphong},
title = {Box–Behnken Design Optimization of High-Pressure Processed Bitter Melon (Momordica charantia) Leaf Extract Enhancing Phytochemicals, Anticancer, and Anti-Inflammatory Activities},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4945},
doi = {10.3390/ijms27114945}
}
EUVIMED